Vaginal candidiasis: a source for fungal peritonitis in peritoneal dialysis?
Castillo
A A
AA
Department of Medicine, The George Washington University Medical Center, Washington, DC, USA.
Lew
S Q
SQ
Smith
A
A
Whyte
R
R
Bosch
J P
JP
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000150:complications*; D003928:Diabetic Nephropathies / Q000628:therapy; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000379:methods; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000382:microbiology*; D006435:Renal Dialysis; D013203:Staphylococcal Infections / Q000188:drug therapy; D013212:Staphylococcus epidermidis
D000900:Anti-Bacterial Agents